Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 993,444 | 942,186 | 893,300 | 789,231 | 773,176 |
| Cost of Goods | 92,401 | 100,934 | 87,566 | 81,613 | 84,063 |
| Gross Profit | 901,043 | 841,252 | 805,734 | 707,618 | 689,113 |
| Operating Expenses | 604,647 | 596,182 | 543,870 | 579,021 | 482,736 |
| Operating Income | 296,797 | 246,004 | 262,430 | 129,210 | 206,440 |
| Other Income | -4,018 | 3,080 | -25,796 | 44,904 | 31,586 |
| Pre-tax Income | 292,779 | 249,084 | 236,634 | 174,114 | 238,026 |
| Income Tax | 84,706 | 83,277 | 93,911 | 54,733 | 51,886 |
| Net Income Continuous | 208,073 | 165,807 | 142,723 | 119,381 | 186,140 |
| Minority Interests | 1,445 | 2,710 | N/A | N/A | N/A |
| Net Income | $206,628 | $163,097 | $201,150 | $119,381 | $186,140 |
| EPS Basic Total Ops | 0.71 | 0.55 | 0.67 | 0.41 | 0.55 |
| EPS Basic Continuous Ops | 0.72 | 0.56 | 0.49 | 0.41 | 0.55 |
| EPS Diluted Total Ops | 0.70 | 0.54 | 0.66 | 0.41 | 0.54 |
| EPS Diluted Continuous Ops | 0.71 | 0.55 | 0.48 | 0.41 | 0.54 |
| EBITDA(a) | $402,336 | $352,936 | $364,693 | $225,965 | $298,900 |